Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 12;11:5129. doi: 10.1038/s41467-020-18860-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 7 — a Representative images of immunohistochemical staining of Zeb1, NICD, and ALDH1 in serial sections of the same tumor (n = 175). Scale bars, 50 μm. b A positive correlation between the expression of Zeb1 and NICD in the 175 human breast cancer samples. c A positive correlation between the expression of Zeb1 and ALDH1 in breast cancer. d A positive correlation between the expression of NICD and ALDH1 in breast cancer. e Concomitantly high expression of Zeb1 and NICD in poorly differentiated high-grade breast cancer. f, g A strong correlation between high expression of Zeb1 (f) and NICD (g) in the TNBC subtype of breast cancer. Indicated P-values were calculated using Spearman’s rank correction test in b–d or Kruskal–Wallis test in e or Kolmogorov–Smirnov test in f, g. Source data are provided as a Source Data file.